Our data observing a striking modulation of PD-L1 mRNA levels depending on the tumor microenvironment, supports that relevant PD-L1 measurement for certain cancer patients needs to be determined in more complex growth models better mimicking in vivo conditions. Here, CD274 is linked to cancer.